(PharmaNewsWire.Com, May 15, 2019 ) Diabetes is a medical condition where blood glucose, or blood sugar, levels are too high. It is a metabolic disorder associated with the hormone insulin and can lead to severe condition with many complications if left untreated. Hence, management of diabetes is essential as maintaining the blood sugar levels in diabetes is challenging. Thus, diabetes management includes keeping the count on carbohydrate intake, measuring and recording the blood sugar level, track record of exercise and other activities.
The global digital diabetes management market is segmented on the basis of product and services, type, end user. Based on product and services, the digital diabetes management market is segmented as devices and software and services. The devices market is further segmented into smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps/closed loop systems & smart insulin patches. By type the market is segmented into wearable devices, handheld devices. Based on end user, the digital diabetes management market is segmented as home care, hospitals & specialty diabetes clinics, and academic & research institutes.
The List of Companies
1. Medtronic 2. F. Hoffmann-La Roche Ltd 3. Glooko, Inc. 4. Omada Health, Inc. 5. B. Braun Melsungen AG 6. Abbott 7. Insulet Corporation 8. Tandem Diabetes Care 9. Ascensia Diabetes Care Holdings AG 10. Smart Meter LLC.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Digital Diabetes Management market based on product and services, type, and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The digital diabetes management market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the digital diabetes management market in the forecast period, due to the increasing prevalence of diabetes, advanced healthcare infrastructure, availability of technologically advanced products in this region as well as the presence of major market players in this region. However, Asia Pacific region is expected to be the fastest growing region owing to availability of several untapped opportunities, and increasing adoption rate of insulin devices in Asian countries, such as India and China.
Key Benefits-
To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa).
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare, Chemicals, Automotive, AnD, Consumer and Telecommunication industries.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
